1 |
Mantel N, Haenszel W (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst, 22, 719-48.
|
2 |
Qin Q, Zhang C, Zhu H, et al (2014). Association between survivin-31G>C polymorphism and cancer risk: metaanalysis of 29 studies. J Cancer Res Clin Oncol, 140, 179-88.
DOI
ScienceOn
|
3 |
Richter AM, Pfeifer GP, Dammann RH (2009). The RASSF proteins in cancer; from epigenetic silencing to functional characterization. Biochim Biophys Acta, 1796, 114-28.
|
4 |
Schagdarsurengin U, Seidel C, Ulbrich EJ, et al (2005). A polymorphism at codon 133 of the tumor suppressor RASSF1A is associated with tumorous alteration of the breast. Int J Oncol, 27, 185-91.
|
5 |
Shivakumar L, Minna J, Sakamaki T, Pestell R, White MA (2002). The RASSF1A tumor suppressor blocks cell cycle progression and inhibits cyclin D1 accumulation. Mol Cell Biol, 22, 4309-18.
DOI
ScienceOn
|
6 |
van der Weyden L, Adams DJ (2007). The Ras-association domain family (RASSF) members and their role in human tumourigenesis. Biochim Biophys Acta, 1776, 58-85.
|
7 |
Donninger H, Barnoud T, Nelson N, et al (2011). RASSF1A and the rs2073498 cancer associated SNP. Front Oncol, 1, 54.
|
8 |
Bergqvist J, Latif A, Roberts SA, et al (2010). RASSF1A polymorphism in familial breast cancer. Fam Cancer, 9, 263-5.
DOI
|
9 |
Borenstein M, Hedges L, Higgins J, Rothstein H (2007). Comprehensive Meta-analysis version 2. Biostat, Inc. Englewood, NJ.
|
10 |
DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials, 7, 177-88.
DOI
ScienceOn
|
11 |
Xiao G, Zhang T, Yao J, et al (2009). The association between RASSF1 gene polymorphisms and lung cancer susceptibility among people in Hubei Province of China. J Huazhong Univ Sci Technolog Med Sci, 29, 646-9.
DOI
ScienceOn
|
12 |
Zhou SL, Cui J, Fan ZM, et al (2013). Polymorphism of A133S and promoter hypermethylation in Ras association domain family 1A gene (RASSF1A) is associated with risk of esophageal and gastric cardia cancers in Chinese population from high incidence area in northern China. BMC Cancer, 13, 259.
DOI
ScienceOn
|
13 |
Meyer A, Coinac I, Bogdanova N, et al (2013). Apoptosis gene polymorphisms and risk of prostate cancer: a hospital-based study of German patients treated with brachytherapy. Urol Oncol, 31, 74-81.
DOI
ScienceOn
|
14 |
Kawai Y, Sakano S, Okayama N, et al (2012). Association of genotype and haplotype with the progression of clear cell renal cell carcinoma in Japanese patients. BJU Int, 110, 1070-5.
DOI
ScienceOn
|
15 |
Liu WJ, Tan XH, Guo BP, et al (2013). Associations between RASSF1A promoter methylation and NSCLC: a metaanalysis of published data.. Asian Pac J Cancer Prev, 14, 3719-24.
과학기술학회마을
DOI
ScienceOn
|
16 |
Donninger H, Vos MD, Clark GJ (2007). The RASSF1A tumor suppressor. J Cell Sci, 120, 3163-72.
DOI
ScienceOn
|
17 |
Egger M, Davey Smith G, Schneider M, Minder C (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34.
DOI
ScienceOn
|
18 |
El-Kalla M, Onyskiw C, Baksh S (2010). Functional importance of RASSF1A microtubule localization and polymorphisms. Oncogene, 29, 5729-40.
DOI
ScienceOn
|
19 |
Gao B, Xie XJ, Huang C, et al (2008). RASSF1A polymorphism A133S is associated with early onset breast cancer in BRCA1/2 mutation carriers. Cancer Res, 68, 22-5.
DOI
ScienceOn
|
20 |
Gordon M, Baksh S (2011). RASSF1A: not a prototypical Ras effector. Small GTPases, 2, 148-57.
DOI
|
21 |
Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003). Measuring inconsistency in meta-analyses. BMJ, 327, 557-60.
DOI
ScienceOn
|
22 |
Higgins JP, Thompson SG (2002). Quantifying heterogeneity in a meta-analysis. Stat Med, 21, 1539-58.
DOI
ScienceOn
|
23 |
Kanzaki H, Hanafusa H, Yamamoto H, et al (2006). Single nucleotide polymorphism at codon 133 of the RASSF1 gene is preferentially associated with human lung adenocarcinoma risk. Cancer Let, 238, 128-34.
DOI
ScienceOn
|
24 |
Akkız H, Bayram S, Bekar A, Akgollu E, Uskudar O (2011). Genetic variation in the MicroRNA-499 gene and hepatocellular carcinoma risk in a Turkish population: lack of any association in a case-control study. Asian Pac J Cancer Prev, 12, 3107-12.
|
25 |
Bayram S, Akkız H, Bekar A, Akgollu E, Yıldırım S (2011). No association of exonuclease 1 T439M polymorphism and risk of hepatocellular carcinoma development in Turkish population: a case-control study. Asian Pac J Cancer Prev, 12, 2455-60.
|
26 |
Vo LT, Thuan TB, Thu DM, et al (2013). Methylation profile of BRCA1, RASSF1A and ER in Vietnamese women with ovarian cancer.. Asian Pac J Cancer Prev, 14, 7713-8..
과학기술학회마을
DOI
ScienceOn
|
27 |
Begg CB, Mazumdar M (1994). Operating characteristics of a rank correlation test for publication bias. Biometrics, 50, 1088-101.
DOI
ScienceOn
|
28 |
Bayram S (2012). RASSF1A Ala133Ser polymorphism is associated with increased susceptibility to hepatocellular carcinoma in a Turkish population. Gene, 498, 264-9.
DOI
ScienceOn
|